Table S2 from Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
TERTwt = TERT promoter wild-type; TERTmut = TERT promoter mutant. *Estimates of mean survival from Kaplan Meier method (median survival not reached); p value estimated using log-rank test. **Based
BackgroundRecent evidence suggests that enhancer RNAs (eRNAs) play key roles in cancers. Identification of immune-related eRNAs (ireRNAs) in melanoma can provide novel insights into the mechanisms und
Human leukocyte antigen (HLA) are essential components of the immune system that stimulate immune cells to provide protection and defense against cancer. Thousands of HLA alleles have been reported in
